UOC
LKFT icon

UBS O'Connor’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

UBS O'Connor’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,888
Closed -$376K – 547
2023
Q3 		$376K Sell
10,888
-46,000
-81% -$1.79M 0.01% 423
2023
Q2 		$2.31M Buy
56,888
+15,638
+38% +$638K 0.05% 266
2023
Q1 		$1.59M Buy
+41,250
New +$1.7M 0.04% 361

Other funds holding LKFT

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return

UBS O'Connor's LKFT Position: Q4 2023 in Review

UBS O'Connor sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2023, closing a stake of 10,888 shares — an estimated $376K sold.

UBS O'Connor first reported a position in LKFT in Q1 2023 and held it in 3 quarters. The position peaked at $2.31M in Q2 2023. 88 funds tracked by Wall St. Rank hold LKFT as of Q4 2023.

  • UBS O'Connor reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2023 after selling out during the quarter.
  • UBS O'Connor sold 10,888 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2023, an estimated $376K.
  • UBS O'Connor first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2023 and held it in 3 quarters.
  • UBS O'Connor's Lakefront Biotherapeutics American Depositary Shares position peaked at $2.31M in Q2 2023.
  • 88 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2023.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.